Richard Close
Stock Analyst at Canaccord Genuity
(2.09)
# 2,841
Out of 4,827 analysts
136
Total ratings
34.07%
Success rate
-8.81%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Hold | $19 → $22 | $23.14 | -4.91% | 13 | May 8, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $10 → $9 | $4.14 | +117.39% | 8 | May 8, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $47 | $40.05 | +17.35% | 5 | May 1, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $14 → $12 | $7.09 | +69.25% | 16 | May 1, 2025 | |
| LFST LifeStance Health Group | Initiates: Buy | $8 | $5.71 | +40.23% | 1 | Apr 3, 2025 | |
| TALK Talkspace | Initiates: Buy | $5 | $3.01 | +66.39% | 1 | Apr 3, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $25.92 | +35.06% | 9 | Mar 13, 2025 | |
| CLOV Clover Health Investments | Maintains: Buy | $4.2 → $4.5 | $3.49 | +28.94% | 3 | Mar 3, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $29 → $30 | $25.35 | +18.34% | 8 | Feb 28, 2025 | |
| PGNY Progyny | Maintains: Hold | $17 → $23 | $20.96 | +9.73% | 6 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $29 → $30 | $28.08 | +6.85% | 6 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.50 | +64.71% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $60 → $71 | $58.92 | +20.50% | 9 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $16 | $9.30 | +72.04% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $2.17 | +177.14% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $115.16 | +5.07% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.41 | +254.61% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.63 | +13,703.68% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $31.85 | -24.65% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $75.77 | +25.38% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $27.77 | -36.08% | 4 | Dec 20, 2018 |
Premier
May 8, 2025
Maintains: Hold
Price Target: $19 → $22
Current: $23.14
Upside: -4.91%
Health Catalyst
May 8, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $4.14
Upside: +117.39%
Waystar Holding
May 1, 2025
Maintains: Buy
Price Target: $50 → $47
Current: $40.05
Upside: +17.35%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $7.09
Upside: +69.25%
LifeStance Health Group
Apr 3, 2025
Initiates: Buy
Price Target: $8
Current: $5.71
Upside: +40.23%
Talkspace
Apr 3, 2025
Initiates: Buy
Price Target: $5
Current: $3.01
Upside: +66.39%
Phreesia
Mar 13, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $25.92
Upside: +35.06%
Clover Health Investments
Mar 3, 2025
Maintains: Buy
Price Target: $4.2 → $4.5
Current: $3.49
Upside: +28.94%
Privia Health Group
Feb 28, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $25.35
Upside: +18.34%
Progyny
Feb 28, 2025
Maintains: Hold
Price Target: $17 → $23
Current: $20.96
Upside: +9.73%
Feb 26, 2025
Maintains: Hold
Price Target: $29 → $30
Current: $28.08
Upside: +6.85%
Feb 26, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $8.50
Upside: +64.71%
Feb 7, 2025
Maintains: Hold
Price Target: $60 → $71
Current: $58.92
Upside: +20.50%
Jan 23, 2025
Maintains: Buy
Price Target: $23 → $16
Current: $9.30
Upside: +72.04%
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.17
Upside: +177.14%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $115.16
Upside: +5.07%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $1.41
Upside: +254.61%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.63
Upside: +13,703.68%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $31.85
Upside: -24.65%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $75.77
Upside: +25.38%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $27.77
Upside: -36.08%